The immunohistochemical findings correlated with differences in beta thymosin expression in saliva of the two peptides: Tβ10 was detectable in 66.7% of patients with primary Sjӧgren syndrome, while Tβ4 sulfoxide was detectable only in 44.4% of patients. The gene discussed is TMSB10; the disease is Sjogren syndrome.